• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期腹膜癌的姑息治疗

Palliative Management of Advanced Peritoneal Carcinomatosis.

作者信息

Lambert Laura A, Hendrix Ryan J

机构信息

Surgical Oncology, Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT 84112, USA.

Division of Surgical Oncology, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01608, USA.

出版信息

Surg Oncol Clin N Am. 2018 Jul;27(3):585-602. doi: 10.1016/j.soc.2018.02.008.

DOI:10.1016/j.soc.2018.02.008
PMID:29935691
Abstract

Despite advances in the management of peritoneal carcinomatosis, morbidity remains high with survival often measured in weeks to months. Patients are often subjected to symptoms and complications that impact quality of life. Much of the management revolves around palliation of symptoms and providing support and resources to address emotional and existential concerns. This article reviews surgical and nonsurgical palliative treatments for the symptoms and complications associated with advanced, incurable peritoneal carcinomatosis. It is important that providers caring for patients with peritoneal carcinomatosis be knowledgeable in the palliative management of this condition, including the usefulness of early palliative care referral.

摘要

尽管在腹膜癌病的管理方面取得了进展,但发病率仍然很高,生存期通常以数周或数月来衡量。患者经常遭受影响生活质量的症状和并发症。大部分管理工作围绕症状的缓解以及提供支持和资源以解决情感和生存问题。本文综述了针对晚期、无法治愈的腹膜癌病相关症状和并发症的手术及非手术姑息治疗。对于照顾腹膜癌病患者的医护人员而言,了解这种疾病的姑息治疗管理,包括早期姑息治疗转诊的作用,非常重要。

相似文献

1
Palliative Management of Advanced Peritoneal Carcinomatosis.晚期腹膜癌的姑息治疗
Surg Oncol Clin N Am. 2018 Jul;27(3):585-602. doi: 10.1016/j.soc.2018.02.008.
2
Palliative Management of Peritoneal Metastases.腹膜转移的姑息治疗。
Ann Surg Oncol. 2018 Aug;25(8):2165-2171. doi: 10.1245/s10434-018-6335-7. Epub 2018 Jan 30.
3
Looking up: Recent advances in understanding and treating peritoneal carcinomatosis.抬头看:理解和治疗腹膜癌病的最新进展。
CA Cancer J Clin. 2015 Jul-Aug;65(4):284-98. doi: 10.3322/caac.21277. Epub 2015 May 4.
4
A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites.姑息治疗在腹膜癌病和恶性腹水管理中的应用。
Surg Oncol Clin N Am. 2021 Jul;30(3):475-490. doi: 10.1016/j.soc.2021.02.004.
5
Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.全腹结肠切除术、盆腔腹膜切除术及末端回肠造口术用于非妇科癌症所致黏液性腹膜癌病的手术姑息治疗。
J Surg Oncol. 2003 Aug;83(4):197-203. doi: 10.1002/jso.10270.
6
Management of Malignant Bowel Obstruction Associated With GI Cancers.胃肠道癌症相关恶性肠梗阻的管理
J Oncol Pract. 2017 Jul;13(7):426-434. doi: 10.1200/JOP.2017.022210.
7
Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis.自膨式金属支架用于缓解腹膜癌患者的恶性胃出口梗阻
World J Gastroenterol. 2016 Nov 21;22(43):9554-9561. doi: 10.3748/wjg.v22.i43.9554.
8
[Peritoneal carcinomatosis: new strategies for more efficacious treatment].[腹膜癌病:更有效治疗的新策略]
Recenti Prog Med. 2002 Sep;93(9):457-62.
9
Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review.老年人的肠梗阻和腹膜癌病。一项系统评价。
Aging Clin Exp Res. 2017 Feb;29(Suppl 1):73-78. doi: 10.1007/s40520-016-0656-9. Epub 2016 Nov 11.
10
The efficacy of self-expanding metal stents for malignant colorectal obstruction by noncolonic malignancy with peritoneal carcinomatosis.非结直肠癌性腹膜转移所致恶性结直肠梗阻中自膨式金属支架的疗效。
Dis Colon Rectum. 2013 Nov;56(11):1228-32. doi: 10.1097/DCR.0b013e3182a411e7.

引用本文的文献

1
Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside.腹膜癌病中的非编码RNA:从实验台到病床
Cancers (Basel). 2024 Aug 25;16(17):2961. doi: 10.3390/cancers16172961.
2
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.PIPAC-奥沙利铂对难治性结直肠和阑尾癌转移患者功能恢复、良好天数和生存的影响:美国 PIPAC 协作 1 期试验的二次分析。
Ann Surg Oncol. 2024 Nov;31(12):7998-8007. doi: 10.1245/s10434-024-15980-9. Epub 2024 Sep 13.
3
Optimal Nozzle Position and Patient's Posture to Enhance Drug Delivery into the Peritoneum during Rotational Intraperitoneal Pressurized Aerosol Chemotherapy in a Swine Model.
猪模型中旋转式腹腔加压气溶胶化疗期间优化喷嘴位置和患者体位以增强药物向腹膜内的递送
J Pers Med. 2022 Oct 31;12(11):1799. doi: 10.3390/jpm12111799.
4
Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery.胃癌和胃食管交界癌:根治性手术后预防腹膜复发的危险因素及预防性治疗
Ann Gastroenterol Surg. 2022 Mar 24;6(4):474-485. doi: 10.1002/ags3.12565. eCollection 2022 Jul.
5
Incomplete Cytoreduction of Colorectal Cancer Peritoneal Metastases: Survival Outcomes by a Cytoreduction Score.结直肠癌腹膜转移的不完全细胞减灭术:基于细胞减灭评分的生存结果
Visc Med. 2022 Apr;38(2):99-108. doi: 10.1159/000522310. Epub 2022 Feb 23.
6
Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists.恶性肠梗阻的当前管理:急性护理外科医生和外科肿瘤学家的一项调查。
Trauma Surg Acute Care Open. 2021 Jun 16;6(1):e000755. doi: 10.1136/tsaco-2021-000755. eCollection 2021.
7
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.《芝加哥腹膜表面恶性肿瘤共识:姑息治疗考虑》。
Ann Surg Oncol. 2020 Jun;27(6):1798-1804. doi: 10.1245/s10434-020-08323-x. Epub 2020 Apr 13.
8
Type I IFN, Ly6C cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination.I 型干扰素、Ly6C 细胞和吞噬细胞支持 TLR 和 CLR 激动剂组合引发的腹膜癌转移的抑制。
Mol Cancer Ther. 2020 Jun;19(6):1232-1242. doi: 10.1158/1535-7163.MCT-19-0885. Epub 2020 Mar 18.
9
A real-time model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models.一种用于优化腹腔内给药的实时模型(eIBUB),可作为活体动物模型的替代方案。
Pleura Peritoneum. 2019 Aug 15;4(3):20190017. doi: 10.1515/pp-2019-0017. eCollection 2019 Sep 1.